ID: ALA5200126

Max Phase: Preclinical

Molecular Formula: C16H17ClN4OS

Molecular Weight: 348.86

Associated Items:

Representations

Canonical SMILES:  CN[C@H](C)c1cc(Cl)ccc1Cn1c(=S)[nH]c(=O)c2[nH]ccc21

Standard InChI:  InChI=1S/C16H17ClN4OS/c1-9(18-2)12-7-11(17)4-3-10(12)8-21-13-5-6-19-14(13)15(22)20-16(21)23/h3-7,9,18-19H,8H2,1-2H3,(H,20,22,23)/t9-/m1/s1

Standard InChI Key:  KMQDMKOHXUMLRM-SECBINFHSA-N

Associated Targets(Human)

Myeloperoxidase 1002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Thyroid peroxidase 64 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 348.86Molecular Weight (Monoisotopic): 348.0812AlogP: 3.37#Rotatable Bonds: 4
Polar Surface Area: 65.61Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.39CX Basic pKa: 9.23CX LogP: 2.80CX LogD: 0.98
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.63Np Likeness Score: -0.96

References

1. Inghardt T, Antonsson T, Ericsson C, Hovdal D, Johannesson P, Johansson C, Jurva U, Kajanus J, Kull B, Michaëlsson E, Pettersen A, Sjögren T, Sörensen H, Westerlund K, Lindstedt EL..  (2022)  Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.,  65  (17.0): [PMID:36005476] [10.1021/acs.jmedchem.1c02141]

Source